High tumor monocyte content predicts long-term survival for patients with operable oesophageal cancer treated with neoadjuvant immunochemotherapy in the LUD2015-005 trial
Fuchs HS., James SA., Carroll TM., Xie PF., Chadwick JA., Parkes D., Lord SR., Griffiths L., Underwood T., Karydis I., Petty RT., Schuster-Bockler B., Owen RP., Middleton MR., Lu X.